DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;

Collaboration

The Pharmaceutical Alliance has worked with a wide range of external stakeholders in the development of DAVE™. A number of medical experts, including diabetes specialists and general practitioners, and third party organisations have provided invaluable advice and feedback to ensure the software is effective in supporting GPs in completing the complex reviews of their type 2 diabetes patients within the time constraints of a typical consult. Third party organisations involved in the development and ongoing rollout of DAVE™ include:

Best Practice Software
Central Sydney GP Network
Locum Software
Rockingham Kwinana Division of General Practice
Perth Primary Care Network
PivotWest

Best Practice Software

Best Practice Software supplies a range of products designed for use in medical practices including Best Practice Clinical, Best Practice Management and Top Pocket.
www.bpsoftware.com.au

Central Sydney GP Network

Central Sydney GP Network (CSGPN) is one of two GP Networks within the Central Sydney area. The CSGPN aims to improve healthcare in the community by supporting, educating and advising local GPs and their staff.
www.csgpn.com.au

Locum Software

Developed by Global Health, Locum is a clinical software application used by GPs, specialists and community health providers for patient management.
www.global-health.com/product_detail.php?productid=4

Rockingham Kwinana Division of General Practice

Rockingham Kwinana Division of General Practice (RKDGP) is a key stakeholder in the development of health services and systems through General Practice. Along with local stakeholder groups such as the City of Rockingham, Town of Kwinana, and Kwinana Industries Council, it engages with the network of local GP Practices and the community to develop programs which address local service gaps.
www.rkdgp.com.au

Perth Primary Care Network

Perth Primary Care Network (PPCN) is a leading not-for-profit organisation in the primary health care sector focusing on the delivery of quality health outcomes to local communities by supporting primary health care providers and consumers.
www.ppcn.com.au

PivotWest

PivotWest (formerly known as Western Melbourne Division of General Practice) provides support and services for and on behalf of general practitioners. PivotWest aims to assist GPs in delivering quality care and outcomes to the people of Western Melbourne, focusing on the local Government areas of Brimbank and Maribyrnong.
www.pivotwest.org.au

Please note that The Pharmaceutical Alliance is not responsible for the content of external websites. By clicking on any of the links above, you will leave the DAVE™ microsite.


	“The Pharmaceutical Alliance is the innovator of the pharmaceutical industry in Australia. Whenever there are new ideas to collaborate around medicines, The Pharmaceutical Alliance is there.” Dr John Aloizos AM, GP from Brisbane and Board member of Australian General Practice Accreditation Ltd and Quality in Practice Pty Ltd. and immediate past Chair of Australian Pharmaceutical Advisory Board (APAC)


	“There are four challenges for us with our patients with diabetes: to prevent the development of type 2 diabetes in the first place; to identify the 50% of diabetics who are currently undiagnosed; to ensure that those known to have diabetes are regularly and proactively reviewed; to ensure that our reviews are comprehensive and cover all aspects of the management of their condition. The first and second challenges can be met through an organised approach to screening and the third by using an efficient recall remind system. The fourth challenge can be met by using simple easy to use software of which The Pharmaceutical Alliance’s electronic diabetes assistance tool is an outstanding example.” Dr Michael Moore, a GP and CEO of the Central Sydney Division of GPs


	“The Rockingham Kwinana DGP has been working closely with The Pharmaceutical Alliance to have a number of GP practices involved in the demonstration pilot and using the diabetes software tool. This has added value to our program delivery and enhanced the capacity of participating practices to improve the management of their diabetic patients at a practice level by enabling a more multidisciplinary team approach.” Kevin Shanks, Deputy Chief Executive Officer, Rockingham Kwinana Division of General Practice

The Pharmaceutical Alliance seeks views and guidance from a broad range of healthcare professionals. Where appropriate for these consultations, the Alliance provides remuneration specifically to cover their time away from day-to-day responsibilities. The Pharmaceutical Alliance has not provided any payment for comments expressed by people regarding the Alliance or its work. All views represent the opinions of the individual author and are independent of The Pharmaceutical Alliance.